DekaBank Deutsche Girozentrale’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,400
Closed -$156K 1269
2023
Q1
$156K Hold
22,400
﹤0.01% 1214
2022
Q4
$202K Hold
22,400
﹤0.01% 1219
2022
Q3
$275K Hold
22,400
﹤0.01% 1170
2022
Q2
$270K Hold
22,400
﹤0.01% 1134
2022
Q1
$437K Buy
22,400
+2,000
+10% +$37.2K ﹤0.01% 1083
2021
Q4
$545K Buy
20,400
+600
+3% +$20.7K ﹤0.01% 1080
2021
Q3
$860K Hold
19,800
﹤0.01% 934
2021
Q2
$911K Hold
19,800
﹤0.01% 935
2021
Q1
$815K Hold
19,800
﹤0.01% 945
2020
Q4
$1.52M Buy
19,800
+2,000
+11% +$82.2K 0.01% 740
2020
Q3
$518K Buy
+17,800
New +$580K ﹤0.01% 925
2019
Q3
Sell
-36,800
Closed -$861K 1027
2019
Q2
$861K Buy
36,800
+5,300
+17% +$127K ﹤0.01% 811
2019
Q1
$1.01M Buy
31,500
+13,100
+71% +$297K 0.01% 762
2018
Q4
$374K Sell
18,400
-13,100
-42% -$357K ﹤0.01% 875
2018
Q3
$1.01M Sell
31,500
-600
-2% -$19.4K 0.01% 776
2018
Q2
$1.15M Buy
32,100
+6,000
+23% +$212K 0.01% 716
2018
Q1
$852K Buy
26,100
+18,700
+253% +$666K 0.01% 755
2017
Q4
$153K Hold
7,400
﹤0.01% 959
2017
Q3
$153K Hold
7,400
﹤0.01% 965
2017
Q2
$127K Buy
+7,400
New +$133K ﹤0.01% 952

Other funds holding EDIT

DekaBank Deutsche Girozentrale's EDIT Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 22,400 shares — an estimated $156K sold.

DekaBank Deutsche Girozentrale first reported a position in EDIT in Q2 2017 and held it in 20 quarters. The position peaked at $1.52M in Q4 2020. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 22,400 Editas Medicine shares in Q2 2023, an estimated $156K.
  • DekaBank Deutsche Girozentrale first reported a position in Editas Medicine in Q2 2017 and held it in 20 quarters.
  • DekaBank Deutsche Girozentrale's Editas Medicine position peaked at $1.52M in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.